Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”

In the article titled “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects” [1], there was an error in the legend of Figure 1 that occurred during the production stage, as the color of the placebo results/bars has been replaced by the colors of the high dose results/bars and vice versa.

Figure 1.

Responder rate for subjects who lost ≥3% and ≥5% of initial body weight at v6. LD = low dose; HD = high dose. ^ap < 0.001 vs. placebo; ^bp=0.026 vs. placebo; ^cp=0.015 vs. low-dose group.

The correct version of Figure 1 should be as follows: